2025-09-25 - Analysis Report
Okay, here's the analysis of Intuitive Surgical (ISRG) based on the data you provided, formatted as requested.

## ISRG Stock Analysis

**Ticker:** ISRG
**Company Name:** Intuitive Surgical Inc.
**Description:** Intuitive Surgical designs, manufactures, and markets robotic surgical systems and related instruments and accessories.

### 1. Performance vs. S&P 500 (VOO)

*   **ISRG Cumulative Return:** 31.58%
*   **VOO Cumulative Return:** 69.58%
*   **Absolute Divergence:** -18.8
*   **Relative Divergence:** 0.4 (Indicates ISRG's performance is near the bottom of its historical divergence range compared to VOO)

**Analysis:** ISRG has significantly underperformed the S&P 500 over the period. The relative divergence indicates that this underperformance is near the bottom end of its historical range. This may suggest a potential for ISRG to catch up, but it's important to consider why the underperformance exists.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha  | Beta  | Cap(B) |
|------------|--------|--------|--------|-------|--------|
| 2015-2017  | 53.0%  | 67.4%  | 28.0%  | -0.0  | 43.6   |
| 2016-2018  | 50.0%  | 99.6%  | 32.0%  | 0.0   | 57.2   |
| 2017-2019  | 39.0%  | 99.6%  | 13.0%  | 0.2   | 70.6   |
| 2018-2020  | -22.0% | 99.8%  | -34.0% | 0.3   | 97.8   |
| 2019-2021  | 25.0%  | 99.8%  | -5.0%  | 0.6   | 128.8  |
| 2020-2022  | -17.0% | 99.8%  | -12.0% | 0.8   | 95.1   |
| 2021-2023  | 7.0%   | 81.7%  | -4.0%  | 0.9   | 120.9  |
| 2022-2024  | 8.0%   | 81.7%  | -16.0% | 0.9   | 187.1  |
| 2023-2025  | 5.0%   | 84.3%  | -34.0% | 0.8   | 161.4  |

**Analysis:**
*   **CAGR:** Shows a decreasing trend in recent years, indicating slowing growth compared to the past.
*   **MDD:** Remains very high, suggesting significant volatility and potential for large drawdowns.
*   **Alpha:** Consistently negative in recent periods, meaning ISRG has underperformed its benchmark on a risk-adjusted basis.
*   **Beta:** Increasing trend suggests ISRG is becoming more correlated with the market (S&P 500).

### 2. Recent Stock Price Action

*   **Current Price:** 450.335
*   **Last Market Data:** {'price': 450.41, 'previousClose': 447.75, 'change': 0.59}
*   **5-Day Moving Average:** 440.619
*   **20-Day Moving Average:** 453.4432
*   **60-Day Moving Average:** 483.8034

**Analysis:** The stock price is slightly above the previous close, indicating a small upward movement. The 5-day moving average is below the current price, suggesting short-term upward momentum. However, the 20-day and 60-day moving averages are above the current price, indicating that the stock is still in a short-term downtrend.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.434 (Medium Risk)
*   **RSI:** 54.84 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.1043 (Positive, but close to zero. Indicates potential for further upward movement.)
*   **Hybrid Signal:** cash_5%_Buy 50% of cash (17 shares - Caution - MRI:0.40) (Cash Ratio: 5% on 2025-09-11)
*   **Recent (20-Day) Relative Divergence Change:** 0.4 (+) (Short-term increase)
*   **Expected Return (%):** 4546.0 (Very high, suggests significant potential outperformance over the S&P 500 in the long term)

**Analysis:** The MRI indicates a medium level of market risk. The RSI is neutral. The positive PPO and recent increase in relative divergence suggests some recent positive momentum.

The hybrid signal recommends caution, suggesting a small buy with a high cash position (95%). The exceptionally high expected return should be viewed with caution as it may be based on overly optimistic assumptions.

The relatively high change from `previousClose` to `price` also indicates a short-term positive move.

### 4. Recent News & Significant Events

*   **Positive Sentiment:**
    *   "Is Most-Watched Stock Intuitive Surgical, Inc. (ISRG) Worth Betting on Now?" - Suggests potential investment opportunity.
    *   "ISRG SP Platform's Expansion in Korea and Europe Gains Traction" - Positive growth catalyst.
    *   "Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains" - Recent outperformance.
    *   "A Fresh Look at Intuitive Surgical (ISRG) Valuation Following New da Vinci 5 Software Innovations" - Suggests potential for value appreciation.
*   **General:**
    *   "How SS Innovations is expanding robotic surgery’s reach" - Competitive landscape context.
    *   "These 2 Growth Stocks Have Been Hammered. Time to Buy?" - Context within broader growth stock market.

**Analysis:** Recent news is generally positive, focusing on growth opportunities (expansion in Korea and Europe), potential value due to new innovations (da Vinci 5 software), and some suggestion of recent stock outperformance.

### 4-2. Analyst Opinions

*   **Consensus:** Buy (Mean: 1.94)
*   **Target Price:**
    *   Average: $582.10
    *   High: $685.00
    *   Low: $350.00
*   **Recent Rating Changes:** (No specific changes provided)

**Analysis:**  Analysts generally have a "Buy" rating on ISRG, and the average target price is significantly above the current price, suggesting upside potential. However, the wide range between the high and low target prices indicates some uncertainty among analysts.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-07-23 | 1.84 | 2.44 B$    |
| 2025-04-23 | 1.95 | 2.25 B$    |
| 2024-10-18 | 1.59 | 2.04 B$    |
| 2024-07-19 | 1.48 | 2.01 B$    |
| 2025-07-23 | 1.48 | 2.01 B$ |

**Analysis:**

*   **EPS:** EPS has varied, with a slight decrease in the most recent quarter, which could be a point of concern.
*   **Revenue:** Revenue shows a generally increasing trend, suggesting healthy business growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $2.44B    | 66.31%        |
| 2025-03-31 | $2.25B    | 64.69%        |
| 2024-12-31 | $2.41B    | 68.04%        |
| 2024-09-30 | $2.04B    | 67.41%        |
| 2024-06-30 | $2.01B    | 68.30%        |

**Capital and Profitability:**

| Quarter    | Equity     | ROE    |
|------------|------------|--------|
| 2025-06-30 | $17.85B   | 3.69%  |
| 2025-03-31 | $17.11B   | 4.08%  |
| 2024-12-31 | $16.43B   | 4.17%  |
| 2024-09-30 | $15.58B   | 3.63%  |
| 2024-06-30 | $14.71B   | 3.58%  |

**Analysis:**

*   **Revenue:** Consistent revenue growth over the past few quarters.
*   **Profit Margin:** High and relatively stable profit margins indicate strong profitability.
*   **Equity:** Growing equity base.
*   **ROE:** Fluctuating ROE, with a recent decrease.

### 7. 종합 Analysis

**Summary:**

ISRG exhibits a mixed picture. While recent news suggests positive developments and analyst consensus leans towards "Buy", the stock has underperformed the S&P 500 significantly. Recent indicators point to potential short-term positive momentum.

**Key Points:**

*   **Underperformance:**  Significant underperformance relative to the S&P 500 needs further investigation. What are the driving factors behind this divergence?
*   **Analyst Optimism:** The analyst target price suggests substantial upside potential.
*   **Financials:** Strong revenue growth, high-profit margins, and a growing equity base are positive signs.
*   **Technicals:** Short-term positive momentum is emerging.
*   **Risk:** The MRI indicates medium market risk, and the stock's high MDD indicates significant volatility.
*   **Expected Return:** Very high expected return should be viewed with caution, as it may be based on overly optimistic assumptions.

**Recommendation:**

The "Hybrid Signal" indicates a suggestion for "cash_5%_Buy 50% of cash" but this has a high degree of cash reserve. With a "Buy" analyst consensus, it may be appropriate to "Buy" considering the expected revenue growth based on recent news.

**Disclaimer:** This analysis is based solely on the provided data and does not constitute financial advice. Conduct thorough research and consult with a financial professional before making any investment decisions.
